Brief: Shilpa Medicare Says Shilpa Biologicals Entered Into A Binding Term Sheet With Mabtree Biologics AG
17/03/2025 11:48
March 17 (Reuters) - Shilpa Medicare Ltd SHME.NS: SHILPA BIOLOGICALS ENTERED INTO A BINDING TERM SHEET WITH MABTREE BIOLOGICS AG TERM SHEET FOR DEVELOPMENT, MANUFACTURE, MARKETING, SALE OF NEW BIOLOGICAL ENTITY Source text: ID:nBSEbZ3Nz0 Further company coverage: SHME.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026